Cytoplasmic IGF2BP2 Protein Expression in Human Patients with Oral Squamous Cell Carcinoma: Prognostic and Clinical Implications

Lin, Shu-Hui; Lin, Chiao-Wen; Lu, Jeng-Wei; Yang, Wei-En; Lin, Yueh-Min; Lu, Hsueh-Ju; Yang, Shun-Fa

doi:10.7150/ijms.74751



Theranostics

International Journal of Biological Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Med Sci 2022; 19(7):1198-1204. doi:10.7150/ijms.74751 This issue Cite

Research Paper

Cytoplasmic IGF2BP2 Protein Expression in Human Patients with Oral Squamous Cell Carcinoma: Prognostic and Clinical Implications

Shu-Hui Lin^1,2, Chiao-Wen Lin^3,4, Jeng-Wei Lu⁵, Wei-En Yang^6,7, Yueh-Min Lin^1,8, Hsueh-Ju Lu^8,9,✉, Shun-Fa Yang^6,7,✉

1. Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan
2. Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan
3. Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan
4. Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan
5. Antimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT-Alliance for Research and Technology, Singapore, Singapore
6. Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
7. Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan
8. School of Medicine, Chung Shan Medical University, Taichung, Taiwan
9. Division of Hematology and Oncology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan

Citation:

Lin SH, Lin CW, Lu JW, Yang WE, Lin YM, Lu HJ, Yang SF. Cytoplasmic IGF2BP2 Protein Expression in Human Patients with Oral Squamous Cell Carcinoma: Prognostic and Clinical Implications. Int J Med Sci 2022; 19(7):1198-1204. doi:10.7150/ijms.74751. https://www.medsci.org/v19p1198.htm

Other styles

Abstract

Oral squamous cell carcinoma (OSCC) is particularly prevalent in Taiwan. The goal of this study was to determine the clinicopathological role of insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) proteins as an indicator of clinical outcomes in OSCC patients. In this study, immunohistochemical (IHC) analysis was used to examine IGF2BP2 protein expression in 244 OSCC patients. We investigated the relationships among IGF2BP2 expression, clinicopathological variables, and patient survival. Our results showed that IGF2BP2 cytoplasmic protein expression was significantly correlated with lymph node metastasis, cancer stage, and patient survival. Kaplan-Meier survival curves revealed that elevated cytoplasmic IGF2BP2 expression levels in OSCC patients were associated with poor overall survival. Moreover, multivariate cox proportional hazard models revealed that cytoplasmic IGF2BP2 expression, T status, and lymph node metastasis were independent prognostic factors for survival. In conclusion, IGF2BP2 protein was found to be a helpful predictive marker for OSCC patients, as well as a possible therapeutic target for OSCC treatment.

Keywords: IGF2BP2, tissue microarray, immunohistochemistry, oral squamous cell carcinoma, survival

Citation styles

APA

Lin, S.H., Lin, C.W., Lu, J.W., Yang, W.E., Lin, Y.M., Lu, H.J., Yang, S.F. (2022). Cytoplasmic IGF2BP2 Protein Expression in Human Patients with Oral Squamous Cell Carcinoma: Prognostic and Clinical Implications. International Journal of Medical Sciences, 19(7), 1198-1204. https://doi.org/10.7150/ijms.74751.

ACS

Lin, S.H.; Lin, C.W.; Lu, J.W.; Yang, W.E.; Lin, Y.M.; Lu, H.J.; Yang, S.F. Cytoplasmic IGF2BP2 Protein Expression in Human Patients with Oral Squamous Cell Carcinoma: Prognostic and Clinical Implications. Int. J. Med. Sci. 2022, 19 (7), 1198-1204. DOI: 10.7150/ijms.74751.

NLM

CSE

Lin SH, Lin CW, Lu JW, Yang WE, Lin YM, Lu HJ, Yang SF. 2022. Cytoplasmic IGF2BP2 Protein Expression in Human Patients with Oral Squamous Cell Carcinoma: Prognostic and Clinical Implications. Int J Med Sci. 19(7):1198-1204.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.